AU2001293064A1 - Use of nitroxides for the treatment of vascular disorders in a diabetic mammal - Google Patents

Use of nitroxides for the treatment of vascular disorders in a diabetic mammal

Info

Publication number
AU2001293064A1
AU2001293064A1 AU2001293064A AU9306401A AU2001293064A1 AU 2001293064 A1 AU2001293064 A1 AU 2001293064A1 AU 2001293064 A AU2001293064 A AU 2001293064A AU 9306401 A AU9306401 A AU 9306401A AU 2001293064 A1 AU2001293064 A1 AU 2001293064A1
Authority
AU
Australia
Prior art keywords
nitroxides
treatment
vascular disorders
diabetic mammal
diabetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001293064A
Other languages
English (en)
Inventor
Christopher S. Wilcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of AU2001293064A1 publication Critical patent/AU2001293064A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001293064A 2000-09-26 2001-09-26 Use of nitroxides for the treatment of vascular disorders in a diabetic mammal Abandoned AU2001293064A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23493300P 2000-09-26 2000-09-26
US60234933 2000-09-26
PCT/US2001/029947 WO2002026231A1 (fr) 2000-09-26 2001-09-26 Utilisation d'oxydes d'azote dans le traitement de troubles vasculaires chez un animal diabetique

Publications (1)

Publication Number Publication Date
AU2001293064A1 true AU2001293064A1 (en) 2002-04-08

Family

ID=22883388

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001293064A Abandoned AU2001293064A1 (en) 2000-09-26 2001-09-26 Use of nitroxides for the treatment of vascular disorders in a diabetic mammal

Country Status (2)

Country Link
AU (1) AU2001293064A1 (fr)
WO (1) WO2002026231A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219201A1 (en) * 2001-12-06 2004-11-04 Yechezkel Barenholz Tempamine compositions and methods of use
AU2004293105B2 (en) * 2003-11-20 2010-09-09 Othera Holding, Inc. Amelioration of macular degeneration and other ophthalmic diseases
US20090062338A1 (en) * 2005-02-02 2009-03-05 Louis Habash Nitroxides for use in treating or preventing cardiovascular disease
JP2008528702A (ja) * 2005-02-02 2008-07-31 ミトス・ファーマシューティカルズ・インコーポレーテッド 免疫疾患の治療又は予防において使用するためのニトロキシド類
JP2008528694A (ja) 2005-02-02 2008-07-31 ミトス・ファーマシューティカルズ・インコーポレーテッド 糖尿病の治療または予防において使用するためのニトロキシド類
US9314457B2 (en) 2014-06-19 2016-04-19 The University Of Utah Research Foundation Methods of treating and preventing vascular instability diseases
RU2751414C1 (ru) * 2020-06-17 2021-07-13 федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный медицинский университет имени В.И. Разумовского" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Саратовский ГМУ им. В.И. Разумовского Минздрава России) Способ коррекции дисфункции эндотелия при нарушениях углеводного обмена, сопровождающихся абсолютной недостаточностью инсулина
US11510913B1 (en) * 2021-05-25 2022-11-29 Louis Habash Modulating expression level of a gene encoding an apurinic/apyrimidinic endodeoxyribonuclease protein by treating a human subject with a nitroxide
US20220378766A1 (en) * 2021-05-25 2022-12-01 Louis Habash Modulating expression level of a gene encoding an uncoupling protein by treating a human subject with a nitroxide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE249829T1 (de) * 1990-03-16 2003-10-15 Us Secretary United States Dep Verwendung von nitroxiden und oxazolidinen zum schutz ionisierender strahlung und oxidativem stress
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
US5406950A (en) * 1993-12-23 1995-04-18 Mallinckrodt Medical, Inc. Inhalable contrast agent

Also Published As

Publication number Publication date
WO2002026231A1 (fr) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2003221906A1 (en) Perfusion guidewire in combination with a distal filter
AU2001272725A1 (en) Intravascular filter
AU2002257241A1 (en) Vascular needle
AU2001271044A1 (en) Safe retained needle
AU2001241603A1 (en) Intravascular filtering devices and methods
AU2001253451A1 (en) Patient compliance monitor
AU775619C (en) Active arterial embolization filter
AU2001237171A1 (en) Vascular occlusion device
AU2002335138A1 (en) Intravascular administration set needle safety device
AU2001231104A1 (en) Methods for treating diabetes
AU2002232104A1 (en) Syringe for use in blood analysis
AU2001252135A1 (en) Therapeutic agents
AU2001255112A1 (en) Device for treating a wound in the skin of a patient
AU2002211351A1 (en) Http transaction monitor with edit and replay capacity
AU2002224443A1 (en) Variable tip catheter
AU2001271644A1 (en) Catheter securing device
AU4647601A (en) Vascular device
AU2001265264A1 (en) Devices and methods for assisting natural heart function
AU2001280598A1 (en) Anti-occlusion catheter
AU2001276146A1 (en) Vascular anchoring device
HUP0300290A3 (en) Combination therapies with vascular damaging activity
AU7065501A (en) Reusable catheter
AU2001293064A1 (en) Use of nitroxides for the treatment of vascular disorders in a diabetic mammal
AU5495101A (en) Ophthalmic injector
AU2002221131A1 (en) Blood lipid ameliorant composition